Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Non Operating Income: 2018-2024

Historic Non Operating Income for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $14.0 million.

  • Gossamer Bio's Non Operating Income fell 31.11% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year decrease of 8.90%. This contributed to the annual value of $14.0 million for FY2024, which is 9.28% down from last year.
  • Per Gossamer Bio's latest filing, its Non Operating Income stood at $14.0 million for FY2024, which was down 9.28% from $15.5 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Non Operating Income registered a high of $15.5 million during FY2023, and its lowest value of -$17.9 million during FY2021.
  • Over the past 3 years, Gossamer Bio's median Non Operating Income value was $14.0 million (recorded in 2024), while the average stood at $6.2 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first crashed by 261.15% in 2020, then spiked by 243.31% in 2023.
  • Gossamer Bio's Non Operating Income (Yearly) stood at -$9.4 million in 2020, then slumped by 90.25% to -$17.9 million in 2021, then skyrocketed by 39.68% to -$10.8 million in 2022, then soared by 243.31% to $15.5 million in 2023, then dropped by 9.28% to $14.0 million in 2024.